General
Preferred name
OLOMOUCINE
Synonyms
P&D ID
PD002661
CAS
101622-51-9
Tags
available
drug candidate
Drug Status
experimental
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Olomoucine is an ATP competitive inhibitor of CDKs. Olomoucine is a purine (HY-34431) derivative and inhibits CDC2/cyclin B, Cdk2/cyclin A, Cdk2/cyclin E (both IC50=7 ¦ÌM), CDK/p35 kinase (IC50=3 ¦ÌM) and ERK1/p44 MAP kinase (IC50=25 ¦ÌM)[1][2]. Olomoucine regulates cell cycle and shows anti-melanin tumor activity[3][4].
PRICE 164
DESCRIPTION Olomoucine is an ATP-competitive inhibitor of Cdk2/cyclin A, Cdc2/CyclinB, CDK2/CyclinE, CDK5/p35, and ERK1/p44 MAP kinase with IC50s of 7, 7, 7, 3, and 25 ??M, respectively. It regulates the cell cycle and exhibits anti-melanin tumor activities.
DESCRIPTION Potent and selective inhibitor of cdc2, cdk and cyclin-dependent kinases (LOPAC library)
DESCRIPTION Cyclin-dependent kinase inhibitor (Tocriscreen Total)
DESCRIPTION Olomoucine is a CDK inhibitor that competes for the ATP binding site of the kinase. Olomoucine was shown to reversibly arrest differentiated Petunia cells induced to divide at G1 phase and cycling Arabidopsis cells in late G1 and G2. (BOC Sciences Bioactive Compounds)
DESCRIPTION Olomoucine is an ATP-competitive inhibitor of Cdk2/cyclin A, Cdc2/CyclinB, CDK2/CyclinE, CDK5/p35, and ERK1/p44 MAP kinase with IC50s of 7, 7, 7, 3, and 25 µM, respectively. It regulates the cell cycle and exhibits anti-melanin tumor activities. (TargetMol Bioactive Compound Library)
Cell lines
9
Organisms
2
Compound Sets
12
BOC Sciences Bioactive Compounds
olomoucine-cas-101622-51-9-item-84-158829
Cayman Chemical Bioactives
10010240
CDK inhibitor database (CDKiDB)
Drug Repurposing Hub
DrugBank
DB02116
DrugMAP
DMNAFG1
DrugMatrix
LOPAC library
MedChem Express Bioactive Compound Library
HY-W011428
Novartis Chemogenetic Library (NIBR MoA Box)
TargetMol Bioactive Compound Library
T21588
Tocriscreen Total
External IDs
31
Properties
(calculated by RDKit )
Molecular Weight
298.15
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
3
Rotatable Bonds
6
Ring Count
3
Aromatic Ring Count
3
cLogP
1.38
TPSA
87.89
Fraction CSP3
0.27
Chiral centers
0.0
Largest ring
6.0
QED
0.64
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Selectivity
PK
Target
Cdc2/CyclinB
Cdc2/CyclinA
CDK2/CyclinE
CDK5/p35
ERK
CDK1, CDK2, CDK5, MAPK1
CDK
Member status
member
MOA
CDK5 Inhibitors
Inhibitors of Signal Transduction Pathways
CDK1 Inhibitors
CDK2 Inhibitors
CDK inhibitor
Pathway
Cell Cycle/Checkpoint
MAPK
Cell Cycle/DNA Damage
Solubility
Soluble in DMSO, Methanol (Slightly)
Source data